Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • World Cup Coverage
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

A new Medicare option for weight loss drugs

Digest more
Top News
Overview
 · 2d · on MSN
Here's what to know about Medicare's new GLP-1 weight-loss drug program
For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 monthly copay.

Continue reading

 · 2d · on MSN
Why Clinicians Worry Medicare’s New $50 Weight-Loss Program Could Backfire
 · 1d
Medicare opens access to GLP-1 weight-loss drugs
 · 1d
Medicare's new $50 weight-loss drug program: Who qualifies and what are the concerns?
Millions of Americans are expected to gain coverage for GLP-1 drugs for weight loss under a new U.S. pilot launching on Wednesday in its Medicare program for people aged 65 and older or with disabilit...

Continue reading

 · 1d
Medicare’s new weight loss drug program just launched and older Americans are expected to flock to it
 · 1d
Pilot program to provide cheaper GLP-1 via Medicare stokes shortage fears
Healthcare Finance News
1d

Medicare launches $50 GLP-1 bridge for eligible Part D beneficiaries

CMS says the 18-month demonstration will expand access to select weight-loss drugs while the agency gathers data on uptake, outcomes and program operations.
MobiHealthNews
2y

Neurology-focused NeuroX will participate in CMS' GUIDE Program

NeuroX, a neurology-focused online consultation service, and its physician network ATP Partners announced it will participate in the Centers for Medicare and Medicaid Services (CMS) GUIDE Program to enhance care for dementia patients. NeuroX, American ...
World Cup Coverage
The latest news on World Cup
See more
  • Privacy
  • Terms